The short version of GHRH analogue fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-27 and is reviewed periodically as new material appears.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Linear polymers with periodic structure, low branching and stereoregularity (e. g. not atactic) have a semi-crystalline structure in the solid state. In simple polymers (such as polyethylene), the chains are present in the crystal in zigzag conformation. Several zigzag conformations form dense chain packs, called crystallites or lamellae. The lamellae are much thinner than the polymers are long (often about 10 nm). They are formed by more or less regular folding of one or more molecular chains. Amorphous structures exist between the lamellae. Individual molecules can lead to entanglements between the lamellae and can also be involved in the formation of two (or more) lamellae (chains than called tie molecules). Several lamellae form a superstructure, a spherulite, often with a diameter in the range of 0.05 to 1 mm. The type and arrangement of (functional) residues of the repeat units effects or determines the crystallinity and strength of the secondary valence bonds. In isotactic polypropylene, the molecules form a helix. Like the zigzag conformation, such helices allow a dense chain packing. Particularly strong intermolecular interactions occur when the residues of the repeating units allow the formation of hydrogen bonds, as in the case of p-aramid. The formation of strong intramolecular associations may produce diverse folded states of single linear chains with distinct circuit topology. Crystallinity and superstructure are always dependent on the conditions of their formation, see also: crystallization of polymers.
Throughout Belize's history, Guatemala has claimed sovereignty over all or part of Belizean territory. This claim is occasionally reflected in maps drawn by Guatemala's government, showing Belize as Guatemala's twenty-third department. The Guatemalan territorial claim involves approximately 53% of Belize's mainland, which includes significant portions of four districts: Belize, Cayo, Stann Creek, and Toledo. Roughly 43% of the country's population (≈154,949 Belizeans) reside in this region. As of 2020, the border dispute with Guatemala remains unresolved and contentious. Guatemala's claim to Belizean territory rests, in part, on Clause VII of the Anglo-Guatemalan Treaty of 1859, which obligated the British to build a road between Belize City and Guatemala. At various times, the issue has required mediation by the United Kingdom, Caribbean Community heads of government, the Organization of American States (OAS), Mexico, and the United States. In April 2018, Guatemala's government held a referendum to determine if the country should take its territorial claim on Belize to the International Court of Justice (ICJ) to settle the long-standing issue. Guatemalans voted 95% yes on the matter. A similar referendum was to be held in Belize in April 2019, but a court ruling led to its postponement. The referendum was held in May 2019, and 55.4% of voters opted to send the matter to the ICJ. Both countries submitted requests to the ICJ (in 2018 and 2019, respectively) and the ICJ ordered Guatemala's initial brief be submitted by December 2020 and Belize's response by 2022.
=== Precursor of nitric oxide === L-Arginine is the sole precursor of nitric oxide in humans and many other animals (NO), one of the smallest messenger substances in the human body. Through the action of NO synthases (nitric oxide synthases), L-arginine is converted into the endothelium-derived relaxing factor (EDRF), which has been identified as NO. Physiologically, EDRF induces vasodilation by diffusing NO into the vascular smooth muscle layer. There, it activates soluble guanylate cyclase, leading to relaxation of the smooth muscle and a reduction in vascular tone. Studies show that arginine can significantly reduce elevated blood pressure through this vasodilatory effect.
== History == The concept of fatty acid (acide gras) was introduced in 1813 by Michel Eugène Chevreul, though he initially used some variant terms: graisse acide and acide huileux ("acid fat" and "oily acid").
Sources: en.wikipedia.org
== Biochemistry == The precursors of ketone bodies include fatty acids from adipose tissue or the diet and ketogenic amino acids. The formation of ketone bodies occurs via ketogenesis in the mitochondrial matrix of liver cells. Fatty acids can be released from adipose tissue by adipokine signaling of high glucagon and epinephrine levels and low insulin levels. High glucagon and low insulin correspond to times of low glucose availability such as fasting. Fatty acids bound to coenzyme A allow penetration into mitochondria. Once inside the mitochondrion, the bound fatty acids are used as fuel in cells predominantly through beta oxidation, which cleaves two carbons from the acyl-CoA molecule in every cycle to form acetyl-CoA. Acetyl-CoA enters the citric acid cycle, where it undergoes an aldol condensation with oxaloacetate to form citric acid; citric acid then enters the tricarboxylic acid cycle (TCA), which harvests a very high energy yield per carbon in the original fatty acid.
== Non-enzymatic processes == Protein backbones are very stable in water at neutral pH and room temperature, although the rate of hydrolysis of different peptide bonds can vary. The half-life of a peptide bond under normal conditions can range from 7 years to 350 years, even higher for peptides protected by modified terminus or within the protein interior. The rate of hydrolysis however can be significantly increased by extremes of pH and heat. Spontaneous cleavage of proteins may also involve catalysis by zinc on serine and threonine. Strong mineral acids can readily hydrolyse the peptide bonds in a protein (acid hydrolysis). The standard way to hydrolyze a protein or peptide into its constituent amino acids for analysis is to heat it to 105 °C for around 24 hours in 6M hydrochloric acid. However, some proteins are resistant to acid hydrolysis. One well-known example is ribonuclease A, which can be purified by treating crude extracts with hot sulfuric acid so that other proteins become degraded while ribonuclease A is left intact. Certain chemicals cause proteolysis only after specific residues, and these can be used to selectively break down a protein into smaller polypeptides for laboratory analysis. For example, cyanogen bromide cleaves the peptide bond after a methionine. Similar methods may be used to specifically cleave tryptophanyl, aspartyl, cysteinyl, and asparaginyl peptide bonds. Acids such as trifluoroacetic acid and formic acid may be used for cleavage. Like other biomolecules, proteins can also be broken down by high heat alone.
William Clark Still (born 1946) is an American organic chemist. As a distinguished professor at Columbia University, Clark Still made significant contributions to the field of organic chemistry, particularly in the areas of natural product synthesis, reaction development, conformational analysis, macrocyclic stereocontrol, and computational chemistry. Still and coworkers also developed the purification technique known as flash column chromatography, which is widely used for the purification of organic compounds.
For services to People with Dementia and their Families. Dr. Emma Lucy Wilson. Director of Technical, Production and Costume, Royal Opera House. For services to the Performing Arts. William Wilson. Senior Officer, National Crime Agency. For services to Law Enforcement. Belinda Ann Winstone. Team Leader, Army Bereavement and Aftercare Services. For services to Military Families. Joan Harris Winterkorn. Archive and Manuscript Consultant and Member, Acceptance in Lieu Panel, Arts Council England. For services to Heritage and Culture. Theresa Wise. Chief Executive, Royal Television Society. For services to Broadcasting. Nicola Clare Wood. Senior Independent Director, Information Commissioner's Office. For services to Regulation. Mary Elizabeth Woods. Lately Nurse Consultant, The Royal Marsden NHS Foundation Trust. For services to Lymphoedema. Caroline Valerie Wright. Early Childhood Director, Bright Horizons Nursery. For services to Early Years Education. Judith Kathleen Wright. Trustee, Orders of St John Care Trust and lately Chair, St John Priory Group for Buckinghamshire. For voluntary service to the Order of St John. Stephen Richard Wright. Broadcaster. For services to Radio. Gloria Ingrid Wyse. Head of Research and Content, Business in the Community. For services to Diversity and Inclusion. Dr. Richard Kenneth Howard Wyse. Director of Clinical Development, Cure Parkinson's. For services to Medicine in Parkinson's Disease. Susan Yates. Officer, National Crime Agency. For services to Law Enforcement. Allan Reid Young. Head of Instrumental Music, Perth and Kinross.
== Epidemiology == Chronic wounds mostly affect people over the age of 60. The incidence is 0.78% of the population and the prevalence ranges from 0.18 to 0.32%. As the population ages, the number of chronic wounds is expected to rise. Ulcers that heal within 12 weeks are usually classified as acute, and longer-lasting ones as chronic.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.